Literature DB >> 3664968

A precursor-product relationship exists between oval cells and hepatocytes in rat liver.

R P Evarts1, P Nagy, E Marsden, S S Thorgeirsson.   

Abstract

Oval cell proliferation was induced in twelve male Fischer rats by administration of 2-acetylaminofluorene (2-AAF) for 2 weeks and by performing partial hepatectomy one week after the beginning of 2-AAF administration. Albumin expression in liver was studied by using in situ hybridization of 3H-labeled rat albumin riboprobe. Radiolabeled thymidine was administered to a group of animals at day 6 after partial hepatectomy. The animals were killed at 0, 3, 7, 9, 11 and 13 days after partial hepatectomy. Both oval cells and basophilic hepatocytes showed a prominent expression of albumin, whereas albumin expression in acidophilic pre-existing hepatocytes was decreased. Oval cell nuclei were exclusively labeled one day after administration of [3H]thymidine. At day 9, 11 and 13 basophilic hepatocytes became labeled and the area occupied by these cells increased. This is the first demonstration of the transfer of radiolabeled thymidine from oval cells to newly formed hepatocytes in vivo. Thus the precursor-product relationship between oval cells and basophilic hepatocytes has been established.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664968     DOI: 10.1093/carcin/8.11.1737

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  128 in total

1.  The facultative stem cell: A new star in liver pathology.

Authors:  Peter Nagy
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

2.  Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury.

Authors:  K M Braun; E P Sandgren
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1.

Authors:  Koichi Shimano; Makoto Satake; Atsuhito Okaya; Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura; Masafumi Sakagami; Nobuyuki Terada; Tohru Tsujimura
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

4.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 5.  Therapeutic application of stem cells in gastroenterology: an up-date.

Authors:  Patrizia Burra; Debora Bizzaro; Rachele Ciccocioppo; Fabio Marra; Anna Chiara Piscaglia; Laura Porretti; Antonio Gasbarrini; Francesco Paolo Russo
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

6.  Sensitivity of the cell cycle to TGF beta 1 does not correlate with transformation of a rat liver epithelial cell line.

Authors:  R Davies; R F Legg; G E Neal
Journal:  Cell Biol Toxicol       Date:  1990-10       Impact factor: 6.691

7.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

8.  Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes.

Authors:  Atsuhito Okaya; Junichi Kitanaka; Nobue Kitanaka; Makoto Satake; Yuna Kim; Kunihiko Terada; Toshihiro Sugiyama; Motohiko Takemura; Jiro Fujimoto; Nobuyuki Terada; Atsushi Miyajima; Tohru Tsujimura
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures.

Authors:  George K Michalopoulos; William C Bowen; Karen Mulè; Jianhua Luo
Journal:  Gene Expr       Date:  2003

10.  Lineage fate of ductular reactions in liver injury and carcinogenesis.

Authors:  Simone Jörs; Petia Jeliazkova; Marc Ringelhan; Julian Thalhammer; Stephanie Dürl; Jorge Ferrer; Maike Sander; Mathias Heikenwalder; Roland M Schmid; Jens T Siveke; Fabian Geisler
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.